Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00080678
What this trial is testing

Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
M.D. Anderson Cancer Center 116
Large-scale testing (Phase 3)Study completedNCT00172055
What this trial is testing

Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy

Who this might be right for
Cancer Prostate
Novartis Pharmaceuticals 218
Not applicableStudy completedNCT04995614
What this trial is testing

Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223

Who this might be right for
Castrate Resistant Prostate CancerBone Metastases
Radboud University Medical Center 122
Early research (Phase 1)Study completedNCT00406939
What this trial is testing

Vector Delivery of the IL-12 Gene in Men With Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate Cancer
Baylor College of Medicine 4
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT00634582
What this trial is testing

Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
Wake Forest University Health Sciences 2
Large-scale testing (Phase 3)Study completedNCT01618370
What this trial is testing

Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Who this might be right for
Prostatic Neoplasms
Bayer 705
Testing effectiveness (Phase 2)Study completedNCT00156884
What this trial is testing

A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate CancerBone Metastases
Alberta Health services 58
Testing effectiveness (Phase 2)Study completedNCT02499835
What this trial is testing

Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
University of Wisconsin, Madison 66
Large-scale testing (Phase 3)Study completedNCT01419717
What this trial is testing

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

Who this might be right for
Bone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast Cancer
Amgen 129
Testing effectiveness (Phase 2)Study completedNCT01940276
What this trial is testing

Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT05502315
What this trial is testing

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerMetastatic Cancer
Rana McKay, MD 47
Early research (Phase 1)Study completedNCT01594918
What this trial is testing

Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Rahul Aggarwal 25
Early research (Phase 1)Study completedNCT00808418
What this trial is testing

Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Synta Pharmaceuticals Corp. 34
Not applicableLooking for participantsNCT06389786
What this trial is testing

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

Who this might be right for
Localized Prostate CarcinomaOligometastatic Prostate CarcinomaStage I Prostate Cancer AJCC v8+3 more
Mayo Clinic 50
Not applicableEnded earlyNCT01760941
What this trial is testing

Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice Patients

Who this might be right for
Symptomatic Osseous Bone Lesions From Any Malignancy
Virginia Commonwealth University 1
Large-scale testing (Phase 3)Looking for participantsNCT05352178
What this trial is testing

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic+4 more
Universitaire Ziekenhuizen KU Leuven 873
Not applicableNot Yet RecruitingNCT06901492
What this trial is testing

The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture

Who this might be right for
PSMA PET/CTProstate CancerMpMRI
Nanjing First Hospital, Nanjing Medical University 120
Testing effectiveness (Phase 2)Study completedNCT00090363
What this trial is testing

ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)

Who this might be right for
Prostate Cancer
AstraZeneca 447
Next Page